# Meridian Bioscience acquires BreathTek business from Otsuka for $20M

Meridian Bioscience signed a definitive agreement to acquire the North American BreathTek business from Otsuka America Pharmaceutical for $20 million in cash. The acquisition includes customer relationships for the urea breath test for H. pylori detection.

- Type: Acquisition
- Announced: 2021-07-23
- Where: United States
- Value: $20.0M
- Status: announced
- Products: urea breath test for H. pylori
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Meridian Bioscience](https://endata.com/companies/39174.md) (acquirer)
- [Otsuka America Pharmaceutical](https://endata.com/companies/56641.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2021/07/23/2268053/0/en/Meridian-Signs-Definitive-Agreement-to-Acquire-Urea-Breath-Test-for-H-pylori-from-Otsuka-America-Pharmaceutical-Inc.html), 2021-07-23: "This is another example of our strategic use of cash generated during the pandemic to further position the diagnostics segment for sustainable growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.